MedicinePsychology

Are the current safety measures for the treatment of depression with esketamine sufficient?

Kyle Valentino, K. Teopiz, Christine Dri, Jennifer Swainson, Y. Zheng, R. McIntyre

2026.2.3Expert Opinion On Drug Safety

DOI: 10.1080/14740338.2026.2627184

Abstract

1. Esketamine as monotherapy or adjunct to conventional antidepressants is proven efficacious in clinical trials in adults with treatment-resistant depression (TRD) and depression with high risk of...

Citation format

VALENTINO, Kyle, et al. Are the current safety measures for the treatment of depression with esketamine sufficient? Expert Opinion On Drug Safety, 2026: 1–3.